logo

27.29

27.29 (0.25%)

As of Jun 14, 2022

Transmedics Group, Inc. [TMDX]

Source: 

Company Overview

Transmedics Group, Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. We developed the OCS to replace a decades-old standard of care that we believe is significantly limiting access to life-saving transplant therapy for hundreds of thousands of patients worldwide.

CountryUnited States
Headquartersandovermassachusetts
Phone Number9785520900
Industry
manufacturing
CEOWaleed H. Hassanein, M.D.
Websitewww.transmedics.com